英国对液化空气收购Vivisol家庭供氧业务展开合并调查

Statutory timetable

Date

Action

19 November 2026

Deadline for phase 1 decision (*)

24 September 2026

Launch of merger inquiry

11 August 2026 to 1 October 2026

Invitation to comment

(*) Whilst the CMA will seek to determine its investigation as quickly as possible, the statutory deadline can be extended in certain limited circumstances.

Phase 1

Launch of merger inquiry

24 September 2026: The CMA announced the launch of its merger inquiry by notice to the parties.

Commencement notice (PDF, 91KB) (24.9.26)

Invitation to comment: closed

The CMA issued this ‘invitation to comment’ to allow interested parties to submit to the CMA any initial views on the impact that the transaction could have on competition in the UK.

To assist with this assessment, the CMA invited comments on the transaction from any interested party by 1 October 2026.

Pre-notification

The CMA has received the necessary information from the parties to commence pre-notification.

Contact

Please send written representations about any competition issues to:

vivisol.airliquidehomeoxygen@cma.gov.uk

Principal Case Officer: Hannah Street, hannah.street@cma.gov.uk

Privacy notice

Your name and contact details are your personal data. In collecting, receiving, storing, accessing and using your personal data, the CMA, as controller, is processing your personal data. The CMA processes personal data in accordance with data protection law. The CMA is processing your personal data so that it can contact you again, should it need further help or information from you, in order to carry out its merger work under Part 3 of the Enterprise Act 2002. For more information about how the CMA processes personal data and your rights relating to that data, please read our personal information charter.